Our leases mainly include our worldwide office and research and development facilities which are all classified as operating leases. Certain leases include renewal options that are under our discretion. The leases expire at various dates through fiscal year 2026, some of which include options to extend the lease for up to 5 years. For the six months ended December 31, 2019, we recorded approximately $4.7 million of operating leases expense. Our short-term leases are immaterial and we do not have finance leases.

As of December 31, 2019, the components of leases and lease costs are as follows (in millions):

	December 31,
	2019
Operating lease right-of-use assets	$	24.8
Operating lease liabilities	$	8.3
Operating lease liabilities, long-term		16.8
Total operating lease liabilities	$	25.1

Supplemental cash flow information related to leases is as follows (in millions):

	Six Months Ended
	December 31,
	2019
Cash paid for operating leases included in operating cash flows	$	4.7
Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets		1.5

As of December 31, 2019, the weighted average remaining lease term is 3.8 years, and the weighted average discount rate is 4.21%.

Future minimum lease payments for the operating lease liabilities are as follows (in millions):

	Operating
	Lease
Fiscal Year	Payments
Remainder of 2020	$	4.7
2021		8.6
2022		5.8
2023		3.7
2024		2.5
Thereafter		1.8
Total future minimum operating lease payments		27.1
Less: interest		(2.0	)
Total lease liabilities	$	25.1

As of the beginning of our fiscal quarter ended September 30, 2019, our aggregate minimum rental commitments for future fiscal years for non-cancelable operating leases with initial or remaining terms in excess of one year were as follows (in millions):

	Operating
	Lease
Fiscal Year	Payments
2020	$	7.4
2021		3.2
2022		0.9
2023		0.3
2024		0.1
Total future minimum operating lease payments	$	11.9